ABSTRACT Background: Psoriasis is primarily a chronic skin disease, the course being punctuated by remissions and relapses. Research has shown that hypertension, obesity, heart failure and diabetes are significantly more common in patients with psoriasis. Obesity is associated with severe psoriasis and is reported about twice as frequently among psoriasis patients as in the general population. In recent years many reports have demonstrated an association between psoriasis and metabolic syndrome. Objectives: The aim of this study was to identify the prevalence of obesity in patients with psoriasis and compare it with that of non-psoriatic population. Material and Method: This study is a case control hospital based study conducted in the Department of Dermatology, Venereology and Leprology of Nepalgunj Medical College Teaching Hospital, Kohalpur between May 2017 to October 2018.Total 56 cases of psoriasis and similar number of healthy age and sex matched controls were enrolled in the study after taking written consent. Detailed history and physical examination was performed with measurement of body mass index which was recorded. Statistical analysis was done using SPSS 20. Result: The results of the study which included 56 patients with psoriasis and 56 subjects without psoriasis. Among them 26 male and 30 female in study population and 25 male and 31 female in control group. The mean age was 41.68±19.04 years in study population and 39.46 ±16.27 years in control group. Duration of disease ranged from 2 months to 360 months and PASI score ranged from 4.4 to 28.2 with mean PASI score 11.02±5.4. BMI in cases ranged from 16.7 to 34.2 with mean 24.3±4.3 and in controls it ranged from 15.5 to 29.1 with mean 21.9±3. Mean BMI was significantly higher in cases than controls.
INTRODUCTION
Psoriasis is a common skin disorder affecting approximately 1-6% of the population in the world. Psoriasis is a chronic skin disease characterized by inflammatory cell infiltration, hyper 1 proliferation of epidermal cells and dilated microvessels . Studies suggest that the disease has bimodal onset, the first peak at the age between 16-22 years and later at 57-60 years of .2 age . Psoriasis tends to occur equally in both the sexes. studies have shown that the mean age of onset is at 33 years of age and 3 75% of cases occurs before the age of 46 years .
The etiopathogenesis of psoriasis is not well understood and various etiological factors have been thought to cause the disease in combination including genetic factors, trauma, infection, environmental factors, drugs, endocrine factors, sunlight, metabolic factors, alcohol, cigarette, and 4 psychological factors . It is characterized by exaggerated and disordered epidermal cell proliferation and keratinization. A host of abnormalities seen in psoriasis, like increased levels of cyclic -adenosine monophosphate (CAMP), epidermal growth factor receptor binding, protein kinase C and transforming growth factors collectively point to a disturbance in T cell function. Currently, the most accepted hypothesis is that psoriasis is an immune-mediated inflammatory skin disease that manifests in a genetically predisposed person exposed to certain environmental agents or triggers. This view has been reinforced by the efficacy of various immunomodulatory 5 agents in the treatment of psoriasis .
Obesity is associated with severe psoriasis and is reported about twice as frequently among psoriasis patients as in the general population. In recent years many reports have demonstrated an association between psoriasis and metabolic syndrome. Metabolic syndrome is combination of: Central obesity, diabetes mellitus type 2, hypertension and 6 dyslipidaemia .
There are several evidences which indicate that psoriasis is closely associated with obesity and hypertension. Herron et al. found that obesity is almost twice as prevalent in patients with 7 psoriasis as in general population.
METHODS
This study is a hospital based Case control study conducted in the Department of Dermatology Venereology & Leprology, Nepalgunj Medical College Teaching Hospital Kohalpur, between May 2017 to October 2018. Before initiating the study the proposal of the study was submitted to the Institutional Review Board. The study population included the patients visiting the OPD of Department of Dermatology, Venereology and Leprology of NGMCTH who were diagnosed as having p s o r i a s i s e i t h e r o n t h e c l i n i ca l g ro u n d a n d /o r histopathologically.
Inclusion criteria included
Case: a) Clinically and/or histopathologically diagnosed cases of psoriasis by a dermatology consultant. b) Age > 16years, belonging to either gender. Altogether 112 (both case and control) patients were included in the study. Diagnosis of psoriasis was made clinically by the consultant dermatologist. The PASI score, BMI were calculated by the author himself. The will of the subjects was fully respected and those who did not give consent for participation were excluded from the study. A written consent was taken from each patient after explaining the relevant details of the study, its importance and implications. Confidentiality was maintained to utmost. Detailed history was taken and detailed clinical examination and investigation was performed and the details were recorded. Statistical analysis was done using SPSS 20. Fisher's exact test was used for significance testing and P value less than 0.05 was considered significant. Odds ratio was used to compare the risk between cases and controls.
Control

RESULTS
A total of 56 cases were included in the study. Fifty six age and sex matched controls were also enrolled. Age of the cases ranged from 18 to 82 years with the mean age 41.68 ± 19.04 years. Age of the controls ranged from 19 to 92 years with mean age 39.46 ± 16.27 years. There was no significant difference in age distribution of cases and controls across the groups (P value = 0.796) as shown in figure 1.
Gender distribution
Out of 56 cases, 26 (46.6%) were male and 30 (53.6%) were female. Out of 56 controls, 25 (44.6) were male and 31 (55.4%) were female as shown in figure 2 . There was no significant difference in proportion of male and female between cases and controls (P value = 1).
Number of cases and controls
Age group in years 
Association of BMI and disease duration
Mean values of disease duration (in months) in psoriatic patients were compared between the groups with BMI <25 2 2 kg/m and BMI ≥ 25 kg/m . There was no significant difference in mean disease duration between the groups which is shown in table V. years . A total of 56 cases and age and sex matched 56 controls were enrolled in this study. Age of the psoriatic patients ranged from 18 to 82 years with mean age 41.68 ±19.04 years and maximum number of patients were of age group 16 to 35 years, 10 which was similar to the study done at TUTH by Shrestha et al . There were slightly higher proportions of female (53.6 %) than male 10 (46.6%) in this study but the study done by Shrestha et al showed slightly higher proportion of male (51.7%) than female (48.3%) however the difference was not statistically significant.
BMI
In this study, Duration of disease ranged from 2 months to 360 months with mean duration of 72.21 ± 67.23 months which was similar to study done by Lakshmi et al171, Madanagobalane et 11 12 al and Gisondi et al . In this study PASI score ranged from 4.4 to 28.2 with mean PASI score 11.02±5.4 which is similar to study done 13 11 by Lakshmi et al Madanagobalane et al . 2 In this study, prevalence of obesity (i.e. BMI ≥ 25kg/m ) was significantly higher in psoriatic patients (37.5%) than controls (17.9%) (P=0.034). Psoriatic patients had 2.8 times increased odds of getting high BMI than controls. Similar result was seen in study 12 14 done by Gisondi et al Kaye et al .
There was no significant difference in the mean PASI score between There was no significant difference in the mean disease duration 2 2 between the groups having BMI ≥ 25 kg/m and BMI <25 kg/m . Similar results were seen in the study done by Madanagobalane et 11 15 16 al and Baeta et al However, the study done by Mallbris et al and 17 Nisa et al had shown positive association between disease duration and BMI.
CONCLUSION
Psoriasis is one of the chronic inflammatory skin diseases, affecting mostly young adults. Different studies have shown its is association with higher prevalence of metabolic syndrome. This study also supports the finding of significantly higher prevalence of obesity in psoriatic patients than control group. Thus, psoriasis should not be regarded as a simple skin disease but rather as a systemic inflammatory disease. The knowledge that psoriasis can be associated with obesity can make dermatologist to screen the psoriatic patient early for obesity and patients can be advised about adapting healthy lifestyle, including diet and exercise.
Limitation of the study
The sample size was small to draw the valid inferences to the larger population
